'Color Doppler stripes' make it difficult to diagnose the severity of valvular heart diseases: a report of two cases.


Journal

Cardiovascular ultrasound
ISSN: 1476-7120
Titre abrégé: Cardiovasc Ultrasound
Pays: England
ID NLM: 101159952

Informations de publication

Date de publication:
07 Oct 2024
Historique:
received: 06 08 2024
accepted: 23 09 2024
medline: 7 10 2024
pubmed: 7 10 2024
entrez: 6 10 2024
Statut: epublish

Résumé

Echocardiography remains the reference-standard imaging technique for assessing valvular heart disease (VHD), but artifacts like the 'color Doppler stripe' can complicate diagnosis. This artifact is not widely recognized and can mimic severe VHD, leading to potential misdiagnoses. We present two cases where color Doppler stripes mimicked severe VHD, highlighting the need for awareness and accurate interpretation in echocardiographic assessments. Case 1: An 85-year-old patient was referred for mitral valve surgery due to suspected severe mitral regurgitation (MR). Upon evaluation, transthoracic echocardiography (TTE) showed mitral valve prolapse (P3) and a high-echoic, vibrating structure attached to the mitral valve, indicative of chordal rupture. Color Doppler echocardiography revealed strong systolic signals in the left atrium, mimicking severe MR. Transesophageal echocardiography (TEE) also detected the vibrating structure and color Doppler stripes in the left atrium, left ventricle, and outside the cardiac chambers. The PISA method on TEE indicated moderate MR and left ventriculography showed Sellers grade II MR. The artifact was identified as color Doppler stripes caused by the vibrating high-echoic structure from the ruptured chorda. Case 2: A 64-year-old patient with severe aortic stenosis, end-stage kidney disease requiring hemodialysis, and a history of coronary bypass grafting presented for routine follow-up. B-mode echocardiography showed a severely calcified tricuspid aortic valve with a vibrating calcified nodule and restricted opening, corresponding to severe aortic stenosis. During systole, color Doppler signals were observed around the aortic, pulmonary, and tricuspid valves, mimicking significant pulmonary stenosis and tricuspid regurgitation. However, pulmonary stenosis was ruled out as the pulmonary valve opening was normal. Mild tricuspid regurgitation was confirmed in the apical view. These cases highlight the diagnostic challenges posed by color Doppler stripes. Recognizing and understanding this artifact are crucial for the accurate diagnosis and management of VHD, ensuring appropriate treatment and patient outcomes.

Sections du résumé

BACKGROUND BACKGROUND
Echocardiography remains the reference-standard imaging technique for assessing valvular heart disease (VHD), but artifacts like the 'color Doppler stripe' can complicate diagnosis. This artifact is not widely recognized and can mimic severe VHD, leading to potential misdiagnoses. We present two cases where color Doppler stripes mimicked severe VHD, highlighting the need for awareness and accurate interpretation in echocardiographic assessments.
CASE PRESENTATIONS METHODS
Case 1: An 85-year-old patient was referred for mitral valve surgery due to suspected severe mitral regurgitation (MR). Upon evaluation, transthoracic echocardiography (TTE) showed mitral valve prolapse (P3) and a high-echoic, vibrating structure attached to the mitral valve, indicative of chordal rupture. Color Doppler echocardiography revealed strong systolic signals in the left atrium, mimicking severe MR. Transesophageal echocardiography (TEE) also detected the vibrating structure and color Doppler stripes in the left atrium, left ventricle, and outside the cardiac chambers. The PISA method on TEE indicated moderate MR and left ventriculography showed Sellers grade II MR. The artifact was identified as color Doppler stripes caused by the vibrating high-echoic structure from the ruptured chorda. Case 2: A 64-year-old patient with severe aortic stenosis, end-stage kidney disease requiring hemodialysis, and a history of coronary bypass grafting presented for routine follow-up. B-mode echocardiography showed a severely calcified tricuspid aortic valve with a vibrating calcified nodule and restricted opening, corresponding to severe aortic stenosis. During systole, color Doppler signals were observed around the aortic, pulmonary, and tricuspid valves, mimicking significant pulmonary stenosis and tricuspid regurgitation. However, pulmonary stenosis was ruled out as the pulmonary valve opening was normal. Mild tricuspid regurgitation was confirmed in the apical view.
CONCLUSIONS CONCLUSIONS
These cases highlight the diagnostic challenges posed by color Doppler stripes. Recognizing and understanding this artifact are crucial for the accurate diagnosis and management of VHD, ensuring appropriate treatment and patient outcomes.

Identifiants

pubmed: 39370511
doi: 10.1186/s12947-024-00331-1
pii: 10.1186/s12947-024-00331-1
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

12

Informations de copyright

© 2024. The Author(s).

Références

Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005–11.
doi: 10.1016/S0140-6736(06)69208-8 pubmed: 16980116
Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol. 2021;18(12):853–64.
doi: 10.1038/s41569-021-00570-z pubmed: 34172950
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632.
doi: 10.1093/eurheartj/ehab395 pubmed: 34453165
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Joint Committee on clinical practice guidelines. Circulation. 2021;143(5):e72–227.
pubmed: 33332150
Izumi C, Eishi K, Ashihara K, Arita T, Otsuji Y, Kunihara T, et al. JCS/JSCS/JATS/JSVS 2020 guidelines on the management of valvular heart disease. Circ J. 2020;84(11):2037–119.
doi: 10.1253/circj.CJ-20-0135 pubmed: 32921646
Patel H, Raisinghani A, DeMaria A. Echocardiography in transcatheter structural heart disease interventions. Prog Cardiovasc Dis. 2018;61(5–6):423–36.
doi: 10.1016/j.pcad.2018.11.009 pubmed: 30465773
Bertrand PB, Levine RA, Isselbacher EM, Vandervoort PM. Fact or artifact in two-dimensional echocardiography: avoiding misdiagnosis and missed diagnosis. J Am Soc Echocardiogr. 2016;29(5):381–91.
doi: 10.1016/j.echo.2016.01.009 pubmed: 26969139 pmcid: 4851918
Suzuki J, Sakamoto T, Hada Y, Amano K, Takahashi H, Hasegawa I, et al. Musical murmurs: phonocardiographic, echocardiographic and Doppler echocardiographic study. J Cardiogr. 1986;16(3):689–97.
pubmed: 3655420
Quien MM, Saric M. Ultrasound imaging artifacts: how to recognize them and how to avoid them. Echocardiography. 2018;35(9):1388–401.
doi: 10.1111/echo.14116 pubmed: 30079966
Wiener PC, Friend EJ, Bhargav R, Radhakrishnan K, Kadem L, Pressman GS. Color Doppler splay: a clue to the presence of significant mitral regurgitation. J Am Soc Echocardiogr. 2020;33(10):1212–9.e1.
doi: 10.1016/j.echo.2020.05.002 pubmed: 32712051
Verbeke J, Kamoen V, Calle S, De Buyzere M, Timmermans F. Color Doppler splay in mitral regurgitation: hemodynamic correlates and outcomes in a clinical cohort. J Am Soc Echocardiogr. 2022;35(9):933–9.
doi: 10.1016/j.echo.2022.04.006 pubmed: 35472569
Allievi L, Bongarzoni A, Tassinario G, Carugo S. Color Doppler splay: a new tool for the assessment of valvular regurgitations? J Am Soc Echocardiogr. 2021;34(9):1021–2.
doi: 10.1016/j.echo.2021.05.003 pubmed: 33984415
Wiener PC, Friend EJ, Pressman GS, Bhargav R, Radhakrishnan K, Kadem L. Response to: “Color Doppler splay: a new tool for the assessment of valvular regurgitations?” by Allievi et al. J Am Soc Echocardiogr. 2021;34(9):1022–3.
doi: 10.1016/j.echo.2021.05.014 pubmed: 34062241

Auteurs

Yuichi Baba (Y)

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Oko-Cho, Nankoku-Shi, Kochi, 783-8505, Japan. ybaba@kochi-u.ac.jp.

Yuri Ochi (Y)

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Oko-Cho, Nankoku-Shi, Kochi, 783-8505, Japan.

Juri Kawaguchi (J)

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Oko-Cho, Nankoku-Shi, Kochi, 783-8505, Japan.

Azumi Takiishi (A)

Department of Clinical Laboratory, Kochi Medical School Hospital, Kochi, Japan.

Daigo Hirakawa (D)

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Oko-Cho, Nankoku-Shi, Kochi, 783-8505, Japan.

Toru Kubo (T)

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Oko-Cho, Nankoku-Shi, Kochi, 783-8505, Japan.

Naohito Yamasaki (N)

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Oko-Cho, Nankoku-Shi, Kochi, 783-8505, Japan.

Hiroaki Kitaoka (H)

Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University, Oko-Cho, Nankoku-Shi, Kochi, 783-8505, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH